Urology eLearning Workshop; A guide to NMIBC - Module 1 Aetiology and Diagnosis of NMIBC

Online Course • medac Pharma

About the CPD course

This is the first module of an eLearning course which features 6 interactive modules; covering a full range of topics within non-muscle invasive bladder cancer. When you finish this module; you should be able to describe the following for NMIBC; Epidemiology; Key risk factors; Common presentations; Standard investigations; Diagnostic findings; Staging and grading systems; Risk and treatment decisions.

CPD Provider

medac Pharma

View Profile

Send an enquiry

Full Name*

Email Address*

Contact Number*

Industry*

Your Enquiry*

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

medac Pharma

medac Pharma is a privately owned, pharmaceutical company specialising in the development, diagnosis and treatment of diseases within the key areas of oncology, urology, haematology and autoimmune. The company was originally founded in Germany in 1970 and the UK operation was established in 1993. Since then we have become known for developing innovative products from standard cancer chemotherapy to niche speciality medicines.